{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:49:02Z","timestamp":1740142142024,"version":"3.37.3"},"reference-count":29,"publisher":"Bentham Science Publishers Ltd.","issue":"14","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG057290","AG053999","NS116058"],"award-info":[{"award-number":["AG057290","AG053999","NS116058"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Alzheimer Disease (AD) pathology has been linked to brain accumulation of &amp;#946; amyloid\n(A&amp;#946;) and neurofibrillary tau tangles. An intriguing question is whether targeting factors independent of\nA&amp;#946; and tau pathologies could delay or even stop neurodegeneration. Amylin, a pancreatic hormone cosecreted\nwith insulin, is believed to play a role in the central regulation of satiation and was shown to\nform pancreatic amyloid in persons with type-2 diabetes mellitus. Accumulating evidence demonstrates\nthat amyloid-forming amylin secreted from the pancreas synergistically aggregates with vascular\nand parenchymal A&amp;#946; in the brain in both sporadic and early-onset familial AD. Pancreatic expression\nof amyloid-forming human amylin in AD-model rats accelerates AD-like pathology, whereas genetically\nsuppressed amylin secretion protects against AD effects. Thus, current data suggest a role of\npancreatic amyloid-forming amylin in modifying AD; further research is required to test whether lowering\ncirculating amylin levels early during AD pathogenesis may curb cognitive decline.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205020666230217091540","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T12:00:42Z","timestamp":1676635242000},"page":"905-908","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bloodborne Pancreatic Amylin, a Therapeutic Target for Alzheimer's\nDisease"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-6449","authenticated-orcid":true,"given":"Florin","family":"Despa","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"Selkoe D.J.","year":"2016","unstructured":"Selkoe D.J.; Hardy J.; The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 2016,8(6),595-608","journal-title":"EMBO Mol Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"Scheltens P.","year":"2016","unstructured":"Scheltens P.; Blennow K.; Breteler M.M.B.; Alzheimer\u2019s disease. Lancet 2016,388(10043),505-517","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"Kahn S.E.","year":"1990","unstructured":"Kahn S.E.; D\u2019Alessio D.A.; Schwartz M.W.; Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 1990,39(5),634-638","journal-title":"Diabetes"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"Westermark P.","year":"2011","unstructured":"Westermark P.; Andersson A.; Westermark G.T.; Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 2011,91(3),795-826","journal-title":"Physiol Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","volume":"69","author":"Lutz T.A.","year":"2012","unstructured":"Lutz T.A.; Control of energy homeostasis by amylin. Cell Mol Life Sci 2012,69(12),1947-1965","journal-title":"Cell Mol Life Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","volume":"19","author":"Banks W.A.","year":"1998","unstructured":"Banks W.A.; Kastin A.J.; Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin. Peptides 1998,19(5),883-889","journal-title":"Peptides"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature13297","volume":"511","author":"Maianti J.P.","year":"2014","unstructured":"Maianti J.P.; McFedries A.; Foda Z.H.; Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature 2014,511(7507),94-98","journal-title":"Nature"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1126\/science.3086977","volume":"232","author":"Bendtzen K.","year":"1986","unstructured":"Bendtzen K.; Mandrup-Poulsen T.; Nerup J.; Nielsen J.H.; Dinarello C.A.; Svenson M.; Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986,232(4757),1545-1547","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"Larsen C.M.","year":"2007","unstructured":"Larsen C.M.; Faulenbach M.; Vaag A.; Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007,356(15),1517-1526","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"Masters S.L.","year":"2010","unstructured":"Masters S.L.; Dunne A.; Subramanian S.L.; Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat Immunol 2010,11(10),897-904","journal-title":"Nat Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"Jackson K.","year":"2013","unstructured":"Jackson K.; Barisone G.A.; Diaz E.; Jin L.; DeCarli C.; Despa F.; Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann Neurol 2013,74(4),517-526","journal-title":"Ann Neurol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2174\/1567205011666141107124538","volume":"11","author":"Fawver J.","year":"2014","unstructured":"Fawver J.; Ghiwot Y.; Koola C.; Islet amyloid polypeptide (IAPP): A second amyloid in Alzheimer\u2019s disease. Curr Alzheimer Res 2014,11(10),928-940","journal-title":"Curr Alzheimer Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","volume":"185","author":"Oskarsson M.E.","year":"2015","unstructured":"Oskarsson M.E.; Paulsson J.F.; Schultz S.W.; Ingelsson M.; Westermark P.; Westermark G.T.; In vivo seeding and cross-seeding of localized amyloidosis: A molecular link between type 2 diabetes and Alzheimer disease. Am J Pathol 2015,185(3),834-846","journal-title":"Am J Pathol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-160047","volume":"53","author":"Verma N.","year":"2016","unstructured":"Verma N.; Ly H.; Liu M.; Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1\u03b2 synthesis in brains of Alzheimer\u2019s disease patients with type-2 diabetes and in diabetic HIP rats. J Alzheimers Dis 2016,53(1),259-272","journal-title":"J Alzheimers Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1177\/0271678X16657093","volume":"37","author":"Schultz N.","year":"2017","unstructured":"Schultz N.; Byman E.; Fex M.; Wennstr\u00f6m M.; Amylin alters human brain pericyte viability and NG2 expression. J Cereb Blood Flow Metab 2017,37(4),1470-1482","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ana.24992","volume":"82","author":"Ly H.","year":"2017","unstructured":"Ly H.; Verma N.; Wu F.; Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. Ann Neurol 2017,82(2),208-222","journal-title":"Ann Neurol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2018.05.003","volume":"69","author":"Schultz N.","year":"2018","unstructured":"Schultz N.; Byman E.; Wennstr\u00f6m M.; Wennstr\u00f6m M.; Levels of retinal IAPP are altered in Alzheimer\u2019s disease patients and correlate with vascular changes and hippocampal IAPP levels. Neurobiol Aging 2018,69,94-101","journal-title":"Neurobiol Aging"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.25570","volume":"86","author":"Martinez-Valbuena I.","year":"2019","unstructured":"Martinez-Valbuena I.; Valenti-Azcarate R.; Amat-Villegas I.; Amylin as a potential link between type 2 diabetes and alzheimer disease. Ann Neurol 2019,86(4),539-551","journal-title":"Ann Neurol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e12130","DOI":"10.1002\/trc2.12130","volume":"7","author":"Ly H.","year":"2021","unstructured":"Ly H.; Verma N.; Sharma S.; The association of circulating amylin with \u03b2\u2010amyloid in familial Alzheimer\u2019s disease. Alzheimers Dement 2021,7(1),e12130","journal-title":"Alzheimers Dement"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1326-9-30","volume":"9","author":"Srodulski S.","year":"2014","unstructured":"Srodulski S.; Sharma S.; Bachstetter A.B.; Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin. Mol Neurodegener 2014,9(1),30","journal-title":"Mol Neurodegener"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.kint.2019.07.028","volume":"97","author":"Verma N.","year":"2020","unstructured":"Verma N.; Liu M.; Ly H.; Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries. Kidney Int 2020,97(1),143-155","journal-title":"Kidney Int"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11306-016-1022-9","volume":"12","author":"Ilaiwy A.","year":"2016","unstructured":"Ilaiwy A.; Liu M.; Parry T.L.; Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo. Metabolomics 2016,12(5),95","journal-title":"Metabolomics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"fcz036","DOI":"10.1093\/braincomms\/fcz036","volume":"2","author":"Royall D.R.","year":"2020","unstructured":"Royall D.R.; Palmer R.F.; Blood-based protein mediators of senility with replications across biofluids and cohorts. Brain Commun 2020,2(1),fcz036","journal-title":"Brain Commun"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/mp.2016.35","volume":"22","author":"Roostaei T.","year":"2017","unstructured":"Roostaei T.; Nazeri A.; Felsky D.; Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer\u2019s disease. Mol Psychiatry 2017,22(2),287-295","journal-title":"Mol Psychiatry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","volume":"45","author":"Wagner T.","year":"2018","unstructured":"Wagner T.; Page J.; Burniston M.; Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: More than hearts and minds. Eur J Nucl Med Mol Imaging 2018,45(7),1129-1138","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=26","first-page":"E531","volume":"275","author":"Castle A.L.","year":"1998","unstructured":"Castle A.L.; Kuo C.H.; Han D.H.; Ivy J.L.; Amylin-mediated inhibition of insulin-stimulated glucose transport in skeletal muscle. Am J Physiol 1998,275(3),E531-E536","journal-title":"Am J Physiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/335632a0","volume":"335","author":"Leighton B.","year":"1988","unstructured":"Leighton B.; Cooper G.J.S.; Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1988,335(6191),632-635","journal-title":"Nature"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF00400848","volume":"35","author":"Zierath J.R.","year":"1992","unstructured":"Zierath J.R.; Galuska D.; Engstr\u00f6m A.; Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in vitro incubated human muscle strips. Diabetologia 1992,35(1),26-31","journal-title":"Diabetologia"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nature13910","volume":"517","author":"Venkatanarayan A.","year":"2015","unstructured":"Venkatanarayan A.; Raulji P.; Norton W.; IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature 2015,517(7536),626-630","journal-title":"Nature"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205020666230217091540","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213740\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205020666230217091540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T21:41:18Z","timestamp":1691790078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213740\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205020666230217091540","relation":{},"ISSN":["1567-2050"],"issn-type":[{"type":"print","value":"1567-2050"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}